Home/Recalls/FDA-98647
FDA DrugsClass II

Bromfenac Ophthalmic Solution 0.07%, 3 ml, Rx only, Sterile, Manufactured for: A...

Published: April 8, 2026Category: drugsCountry: US

Reason for Recall / Hazard

Failed Impurities/Degradation Specifications: out of specification at the time of testing i.e. 20th month stability testing.

Product Description & Identification

Bromfenac Ophthalmic Solution 0.07%, 3 ml, Rx only, Sterile, Manufactured for: Alembic Pharmaceuticals, Inc., Bedminster, NJ 07921, USA, Made in India, Manufactured by: Alembic Pharmaceuticals Limited, Karakhadi- 391 450, Gujarat, India NDC 62332-583-03.

Additional Source Details

FieldValue
CityBedminster
StateNJ
Openfda › Unii8ECV571Y37
Openfda › RouteOPHTHALMIC
Openfda › Rxcui1375917
Openfda › Spl ide680d513-20c9-4595-a293-d3f57d24f428
Openfda › Brand nameBROMFENAC SODIUM
Openfda › Spl set idf6911061-d00e-466d-b623-f81730f38f98
Openfda › Package ndc62332-583-03
Openfda › Product ndc62332-583
Openfda › Generic nameBROMFENAC SODIUM
Openfda › Product typeHUMAN PRESCRIPTION DRUG
Openfda › Substance nameBROMFENAC SODIUM
Openfda › Manufacturer nameAlembic Pharmaceuticals Inc.
Openfda › Application numberANDA214340
Openfda › Is original packagertrue
Event id98647
Address 1550 Hills Dr Ste 104b
Code infoLot # 7240184, 7240185, 7240186, 7240187, Exp Date: 3/31/2026; Lot # 7240278, Exp Date: 5/31/2026.
Postal code07921-1537
Report date20260408
Product typeDrugs
Reason for recallFailed Impurities/Degradation Specifications: out of specification at the time of testing i.e. 20th month stability testing.
Voluntary mandatedVoluntary: Firm initiated
Recall initiation date20260318
Initial firm notificationLetter
Center classification date20260331

Overview

  • Recalling FirmALEMBIC PHARMACEUTICALS, INC.
  • StatusOngoing
  • Risk LevelClass II
  • DistributionNationwide in the USA
Official Agency Alert